companydata.dkEmbryoTrans Biotech ApS: Financial statements 2018
CVR: 36701676
EmbryoTrans Biotech ApS (CVR 36701676) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,135,620 and a net result of DKK -17,779 compared with DKK 172,405 the year before. That is a decrease of 38.2% compared with the year before. Equity amounted to DKK 259,622. The solvency ratio was 34.8%.
- Gross Profit
- 1,135,620 kr.
- Profit/Loss
- -17,779 kr.
- Equity
- 259,622 kr.
- Total Assets
- 745,402 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 1.1 mio. | -18 t. | 260 t. | - |
| 2017 | - | 1.8 mio. | 172 t. | 377 t. | - |
| 2016 | - | 1.8 mio. | 132 t. | 455 t. | - |
Keep an eye on EmbryoTrans Biotech ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
EmbryoTrans Biotech ApS has published its annual report for 2017. Gross profit came to DKK 1,838,431, and the net result was DKK 172,405.
About EmbryoTrans Biotech ApS
EmbryoTrans Biotech ApS was a Danish company of the type Anpartsselskab based in Hundested, founded in 2015 and dissolved in 2022. The company was registered under the industry Detailhandel med medicinske og ortopædiske artikler. The company has 4 employees. In 2020, the company reported a gross profit of DKK 520,019 and a net result of DKK -10,407 compared with DKK 23,111 the year before. Equity amounted to DKK 242,326.